Seres Therapeutics (MCRB) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Seres Therapeutics (MCRB) over the last 10 years, with Q3 2025 value amounting to $618000.0.
- Seres Therapeutics' Interest & Investment Income fell 521.47% to $618000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 5966.19%. This contributed to the annual value of $4.0 million for FY2024, which is 4566.5% down from last year.
- Latest data reveals that Seres Therapeutics reported Interest & Investment Income of $618000.0 as of Q3 2025, which was down 521.47% from $546000.0 recorded in Q2 2025.
- In the past 5 years, Seres Therapeutics' Interest & Investment Income registered a high of $2.6 million during Q3 2023, and its lowest value of $384000.0 during Q1 2022.
- Over the past 5 years, Seres Therapeutics' median Interest & Investment Income value was $829000.0 (recorded in 2021), while the average stood at $998842.1.
- As far as peak fluctuations go, Seres Therapeutics' Interest & Investment Income surged by 102027.03% in 2021, and later tumbled by 7782.85% in 2024.
- Quarter analysis of 5 years shows Seres Therapeutics' Interest & Investment Income stood at $485000.0 in 2021, then skyrocketed by 191.55% to $1.4 million in 2022, then skyrocketed by 39.39% to $2.0 million in 2023, then plummeted by 77.83% to $437000.0 in 2024, then skyrocketed by 41.42% to $618000.0 in 2025.
- Its Interest & Investment Income was $618000.0 in Q3 2025, compared to $546000.0 in Q2 2025 and $618000.0 in Q1 2025.